Affect and cannabis use in daily life: a review and recommendations for future research

Drug and Alcohol Dependence

Volumn 191, Issue , 2018, Pages 223-233

  Wycoff, Andrea M ^a   Metrik, Jane ^b,c   Trull, Timothy J ^a  

^a UNIVERSITY OF MISSOURI   (United States)

^b BROWN UNIVERSITY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cannabis; Ecological momentary assessment; Marijuana; Negative affect; Positive affect

Indexed keywords

CANNABIS;

ANGER; ANXIETY; BIPOLAR DISORDER; CANNABIS USE; CLINICAL OUTCOME; CLINICAL STUDY; COMMUNITY; DAILY LIFE ACTIVITY; DEPRESSION; ECOLOGICAL MOMENTARY ASSESSMENT; HOSTILITY; HUMAN; LIFE EXPECTANCY; MENTAL DISEASE; MOOD DISORDER; MOTIVATION; NEGATIVE AFFECT; POSITIVE AFFECT; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SADNESS; SYSTEMATIC REVIEW; AFFECT; CANNABIS ADDICTION; DRUG EFFECT; FEMALE; FORECASTING; MALE; MEDICAL RECORD; MEDICAL RESEARCH; PHYSIOLOGY; PSYCHOLOGY; RETROSPECTIVE STUDY; STANDARDS; TRENDS;

AFFECT; ANGER; BIOMEDICAL RESEARCH; CANNABIS; FEMALE; FORECASTING; HUMANS; MALE; MARIJUANA ABUSE; MARIJUANA USE; MEDICAL RECORDS; MOTIVATION; RETROSPECTIVE STUDIES;

EID: 85051925761     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2018.07.001     Document Type: Review

References (75)

1. Agosti, V., Nunes, E., Levin, F., Rates of psychiatric comorbidity among U.S. Residents with lifetime cannabis dependence. Am. J. Drug Alcohol Abuse 28 (2002), 643–652.
2. Agrawal, A., Budney, A.J., Lynskey, M.T., The Co-occurring Use and Misuse of Cannabis and Tobacco: a Review. Addicti 107 (2012), 1221–1233.
3. Ansell, E.B., Laws, H.B., Roche, M.J., Sinha, R., Effects of marijuana use on impulsivity and hostility in daily life. Drug Alcohol Depend. 148 (2015), 136–142.
4. Appelbaum, M., Cooper, H., Kline, R.B., Mayo-Wilson, E., Nezu, A.M., Rao, S.M., Journal article reporting standards for quantitative research in psychology: the APA publications and Communications Board task force report. Am. Psychol. 73 (2018), 3–25.
5. Baker, T.B., Piper, M.E., McCarthy, D.E., Majeskie, M.R., Fiore, M.C., Addiction motivation reformulated: an affective processing model of negative reinforcement. Psychol. Rev. 111 (2004), 33–51.
6. Berridge, K.C., Robinson, T.E., Liking, wanting, and the incentive-sensitization theory of addiction. Am. Psychol. 71 (2016), 670–679.
7. Bhushan, D., Blood, E.A., Shrier, L.A., Momentary affective states predicting substance use events in depressed youth. Ment. Health Subst. Use 6 (2013), 203–218.
8. Blanco, C., Hasin, D.S., Wall, M.M., Flórez-Salamanca, L., Hoertel, N., Wang, S., Kerridge, B.T., Olfson, M., Cannabis use and risk of psychiatric disorders: prospective evidence from a US national longitudinal study. JAMA Psychiatry 73 (2016), 388–395.
9. Bonn-Miller, M.O., Boden, M.T., Bucossi, M.M., Babson, K.A., Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users. Am. J. Drug Alcohol Abuse 40 (2014), 23–30.
10. Buckner, J.D., Zvolensky, M.J., Smits, J.A., Norton, P.J., Crosby, R.D., Wonderlich, S.A., Schmidt, N.B., Anxiety sensitivity and marijuana use: an analysis from ecological momentary assessment. Depress. Anxiety 28 (2011), 420–426.
11. Buckner, J.D., Crosby, R.D., Silgado, J., Wonderlich, S.A., Schmidt, N.B., Immediate antecedents of marijuana use: an analysis from ecological momentary assessment. J. Behav. Ther. Exp. Psychiatry 43 (2012), 647–655.
12. Buckner, J.D., Crosby, R.D., Wonderlich, S.A., Schmidt, N.B., Social anxiety and cannabis use: an analysis from ecological momentary assessment. J. Anxiety Disord. 26 (2012), 297–304.
13. Buckner, J.D., Heimberg, R.G., Schneier, F.R., Liu, S.M., Wang, S., Blanco, C., The relationship between cannabis use disorders and social anxiety disorder in the National Epidemiological Study of Alcohol and Related Conditions (NESARC). Drug Alcohol Depend. 124 (2012), 128–134.
14. Buckner, J.D., Zvolensky, M.J., Ecker, A.H., Cannabis use during a voluntary quit attempt: an analysis from ecological momentary assessment. Drug Alcohol Depend. 132 (2013), 610–616.
15. Buckner, J.D., Zvolensky, M.J., Crosby, R.D., Wonderlich, S.A., Ecker, A.H., Richter, A., Antecedents and consequences of cannabis use among racially diverse cannabis users: an analysis from ecological momentary assessment. Drug Alcohol Depend. 147 (2015), 20–25.
16. Budney, A.J., Moore, B.A., Vandrey, R.G., Hughes, J.R., The time course and significance of cannabis withdrawal. J. Abnorm. Psychol. 112 (2003), 393–402.
17. Chakroun, N., Johnson, E.I., Swendsen, J., Mood and personality-based models of substance use. Psychol. Addict. Behav. 24 (2010), 129–136.
18. Chen, C.Y., Wagner, F.A., Anthony, J.C., Marijuana use and the risk of major depressive episode: epidemiological evidence from the United States National Comorbidity Survey. Soc. Psychiatry Psychiatr. Epidemiol. 37 (2002), 199–206.
19. Conway, K.P., Compton, W., Stinson, F.S., Grant, B.F., Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J. Clin. Psychiatr. 67 (2006), 247–257.
20. Cooper, Z.D., Haney, M., Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor. Addict. Biol. 13 (2008), 188–195.
21. Cougle, J.R., Hakes, J.K., Macatee, R.J., Chavarria, J., Zvolensky, M.J., Quality of life and risk of psychiatric disorders among regular users of alcohol, nicotine, and cannabis: an analysis of the National Epidemiological Survey on Alcohol and Related Conditions (NESARC). J. Psychiatr. Res. 66 (2015), 135–141.
22. Davis, A.K., Bonar, E.E., Ilgen, M.A., Walton, M.A., Perron, B.E., Chermack, S.T., Factors associated with having a medical marijuana card among Veterans with recent substance use in VA outpatient treatment. Addict. Behav. 63 (2016), 132–136.
23. Farris, S.G., Metrik, J., Bonn-Miller, M.O., Kahler, C.W., Zvolensky, M.J., Anxiety sensitivity and distress intolerance as predictors of cannabis dependence symptoms, problems, and craving: the mediating role of coping motives. J. Stud. Alcohol Drugs 77 (2016), 889–897.
24. Fusar-Poli, P., Crippa, J.A., Bhattacharyya, S., Borgwardt, S.J., Allen, P., Martin-Santos, R., Seal, M., Surguladze, S.A., O'Carrol, C., Atakan, Z., Zuardi, A.W., McGuire, P.K., Distinct effects of Δ 9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing. JAMA Psychiatry 66 (2009), 95–105, 10.1001/archgenpsychiatry.2008.519.
25. George, O., Koob, G.F., Overview of nicotine withdrawal and negative reinforcement (preclinical). Hall, F.S., Young, J.W., Der-Avakian, A., (eds.) Negative Affective States and Cognitive Impairments in Nicotine Dependence, 2017, Academic Press, New York, 1–20.
26. Grotenhermen, F., Pharmacokinetics and pharmacodynamics of cannabinoids. Clin. Pharmacokinet. 42 (2003), 327–360.
27. Gruber, S.A., Sagar, K.A., Dahlgren, M.K., Olson, D.P., Centorrino, F., Lukas, S.E., Marijuana impacts mood in bipolar disorder: a pilot study. Ment. Health Subst. Use 5 (2012), 228–239.
28. Hamilton, M., The assessment of anxiety states by rating. Br. J. Med. Psychol. 32 (1959), 50–55.
29. Haney, M., Evins, A.E., Does cannabis cause, exacerbate or ameliorate psychiatric disorders? An oversimplified debate discussed. Neuropsychopharmacology 41 (2016), 393–401.
30. Haney, M., Ward, A.S., Comer, S.D., Foltin, R.W., Fischman, M.W., Abstinence symptoms following smoked marijuana in humans. Psychopharmacology 141 (1999), 395–404.
31. Hart, C.L., van Gorp, W., Haney, M., Foltin, R.W., Fischman, M.W., Effects of acute smoked marijuana on complex cognitive performance. Neuropsychopharmacology 25 (2001), 757–765.
32. Hartman, R.L., Huestis, M.A., Cannabis effects on driving skills. Clin. Chem. 59 (2013), 478–492.
33. Henquet, C., van Os, J., Kuepper, R., Delespaul, P., Smits, M., à Campo, J., Myin-Germeys, I., Psychosis reactivity to cannabis use in daily life: an experience sampling study. B. J. Psychiatry 196 (2010), 447–453.
34. Hughes, J.R., Fingar, J.R., Budney, A.J., Naud, S., Helzer, J.E., Callas, P.W., Marijuana use and intoxication among daily users: an intensive longitudinal study. Addict. Behav. 39 (2014), 1464–1470.
35. Kevorkian, S., Bonn-Miller, M.O., Belendiuk, K., Carney, D.M., Roberson-Nay, R., Berenz, E.C., Associations among trauma, posttraumatic stress disorder, cannabis use, and cannabis use disorder in a nationally representative epidemiologic sample. Psychol. Addict. Behav. 29 (2015), 633–638.
36. Koob, G.F., Volkow, N.D., Neurocircuitry of addiction. Neuropsychopharmacology 35 (2010), 217–238.
37. Kuepper, R., Oorschot, M., Myin‐Germeys, I., Smits, M., van Os, J., Henquet, C., Is psychotic disorder associated with increased levels of craving for cannabis? An experience sampling study. Acta Psychiatr. Scand. 128 (2013), 448–456.
38. Lee, M.A., Smoke Signals: a Social History of Marijuana—medical, Recreational, and Scientific. 2012, Scribner, New York.
39. Lev-Ran, S., Roerecke, M., Le Foll, B., George, T.P., McKenzie, K., Rehm, J., The association between cannabis use and depression: a systematic review and meta-analysis of longitudinal studies. Psychol. Med. (Paris) 44 (2014), 797–810.
40. Lex, B.W., Griffin, M.L., Mello, N.K., Mendelson, J.H., Alcohol, marijuana, and mood states in young women. Int. J. Addict. 24 (1989), 405–424.
41. Lukas, S.E., Orozco, S., Ethanol increases plasma Δ9-tetrahydrocannabinol (THC) levels and subjective effects after marihuana smoking in human volunteers. Drug Alcohol Depend. 64 (2001), 143–149.
42. McDonald, J., Schleifer, L., Richards, J.B., de Wit, H., Effects of THC on behavioral measures of impulsivity in humans. Neuropsychopharmacology 28 (2003), 1356–1365.
43. McNair, D.M., Lorr, M., Droppleman, L.F., EdITS Manual for the Profile of Mood States. 1992, Educational and Industrial Testing Service, San Diego, CA.
44. Mechoulam, R., Parker, L.A., The endocannabinoid system and the brain. Annu. Rev. Psychol. 64 (2013), 21–47.
45. Mehmedic, Z., Chandra, S., Slade, D., Denham, H., Foster, S., Patel, A.S., Ross, S.A., Khan, I.A., ElSohly, M.A., Potency trends of Δ 9-THC and other cannabinoids in confiscated cannabis preparations from 1993 to 2008. J. Forensic Sci. 55 (2010), 1209–1217.
46. Metrik, J., Rohsenow, D.J., Understanding the role of substance expectancies in addiction. MacKillop, J., de Wit, H., (eds.) Handbook of Addiction Psychopharmacology. The Wiley-Blackwell Press, 2013, 459–487.
47. Metrik, J., Kahler, C.W., McGeary, J.E., Monti, P.M., Rohsenow, D.J., Acute effects of marijuana smoking on negative and positive affect. J. Cogn. Psychother. 25 (2011), 31–46.
48. Metrik, J., Jackson, K., Bassett, S.S., Zvolensky, M.J., Seal, K., Borsari, B., The mediating roles of coping, sleep, and anxiety motives in cannabis use and problems among returning veterans with PTSD and MDD. Psychol. Addict. Behav. 30 (2016), 743–754.
49. Metrik, J., Farris, S.G., Aston, E.R., Kahler, C.W., Development and initial validation of a marijuana cessation expectancies questionnaire. Drug Alcohol Depend. 177 (2017), 163–170.
50. Metrik, J., Bassett, S., Aston, E.R., Jackson, K., Borsari, B., Medicinal versus recreational cannabis use among returning veterans. Transl. Issues Psychol. Sci. 4 (2018), 6–20.
51. Morgan, C.J.A., Gardener, C., Schafer, G., Swan, S., Demarchi, C., Freeman, T.P., Warrington, P., Rupasinghe, I., Ramoutar, A., Tan, N., Wingham, G., Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being. Psychol. Med. (Paris) 42 (2012), 391–400.
52. National academies of sciences, engineering, and medicine. The Health Effects of Cannabis and Cannabinoids: the Current State of Evidence and Recommendations for Research, 2017, The National Academies Press, Washington, DC https://www.nap.edu/catalog/24625/the-health-effects-of-cannabis-and-cannabinoids-the-current-state.
53. Niesink, R.J., van Laar, M.W., Does cannabidiol protect against adverse psychological effects of THC?. Front. Psychiatry 4 (2013), 130–135.
54. Osborn, L.A., Lauritsen, K.J., Cross, N., Davis, A.K., Rosenberg, H., Bonadio, F., Lang, B., Self-medication of somatic and psychiatric conditions using botanical marijuana. J. Psychoactive Drugs 47 (2015), 345–350.
55. Phan, K.L., Angstadt, M., Golden, J., Onyewuenyi, I., Popovska, A., de Wit, H., Cannabinoid modulation of amygdala reactivity to social signals of threat in humans. J. Neurosci. 28 (2008), 2313–2319.
56. Piasecki, T.M., Hedeker, D., Dierker, L.C., Mermelstein, R.J., Progression of nicotine dependence, mood level, and mood variability in adolescent smokers. Psychol. Addict. Behav. 30 (2016), 484–493.
57. Reinarman, C., Nunberg, H., Lanthier, F., Heddleston, T., Who are medical marijuana patients? Population characteristics from nine California assessment clinics. J. Psychoactive Drugs 43 (2011), 128–135.
58. Robinson, T.E., Berridge, K.C., The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev. 18 (1993), 247–291.
59. Robinson, T.E., Berridge, K.C., Addiction. Annu. Rev. Clin. Psychol. 54 (2003), 25–53.
60. Ross, C.S., Brooks, D.R., Aschengrau, A., Siegel, M.B., Weinberg, J., Shrier, L.A., Positive and negative affect following marijuana use in naturalistic settings: an ecological momentary assessment study. Addict. Behav. 76 (2018), 61–67.
61. Sagar, K.A., Dahlgren, M.K., Racine, M.T., Dreman, M.W., Olson, D.P., Gruber, S.A., Joint effects: a pilot investigation of the impact of bipolar disorder and marijuana use on cognitive function and mood. PLoS One, 11, 2016, e0157060.
62. Schauer, G.L., Rosenberry, Z.R., Peters, E.N., Marijuana and tobacco co-administration in blunts, spliffs, and mulled cigarettes: a systematic literature review. Addict. Behav. 64 (2017), 200–211.
63. Shrier, L.A., Ross, C.S., Blood, E.A., Momentary positive and negative affect preceding marijuana use events in youth. J. Stud. Alcohol Drugs 75 (2014), 781–789.
64. Stinson, F.S., Ruan, W.J., Pickering, R., Grant, B.F., Cannabis use disorders in the USA: prevalence, correlates and co-morbidity. Psychol. Med. (Paris) 36 (2006), 1447–1460.
65. Stone, A.A., Shiffman, S., Ecological momentary assessment (EMA) in behavioral medicine. Ann. Behav. Med. 16 (1994), 199–202.
66. Swendsen, J., Ben-Zeev, D., Granholm, E., Real-time electronic ambulatory monitoring of substance use and symptom expression in schizophrenia. Am. J. Psychiatry 168 (2011), 202–209.
67. Tournier, M., Sorbara, F., Gindre, C., Swendsen, J.D., Verdoux, H., Cannabis use and anxiety in daily life: a naturalistic investigation in a non-clinical population. Psychiatry Res. 118 (2003), 1–8.
68. Trull, T.J., Ebner-Priemer, U.W., Ambulatory assessment. Annu. Rev. Clin. Psychol. 9 (2013), 151–176.
69. Trull, T.J., Wycoff, A.M., Lane, S.P., Carpenter, R.W., Brown, W.C., Cannabis and alcohol use, affect, and impulsivity in psychiatric outpatients’ daily lives. Addict. 111 (2016), 2052–2059.
70. Tyler, E., Jones, S., Black, N., Carter, L.A., Barrowclough, C., The relationship between bipolar disorder and cannabis use in daily life: an experience sampling study. PLoS One, 10, 2015, e0118916.
71. Volkow, N.D., Hampson, A.J., Baler, R.D., Don't worry, be happy: endocannabinoids and cannabis at the intersection of stress and reward. Annu. Rev. Pharmacol. Toxicol. 57 (2017), 285–308.
72. Walsh, Z., Gonzalez, R., Crosby, K., Thiessen, M., Carroll, C., Bonn-Miller, M.O., Medical cannabis and mental health: a guided systematic review. Clin. Psychol. Rev. 51 (2017), 15–29.
73. Weinberger, A.H., Platt, J., Goodwin, R.D., Is cannabis use associated with an increased risk of onset and persistence of alcohol use disorders? A three-year prospective study among adults in the United States. Drug Alcohol Depend. 161 (2016), 363–367.
74. Winward, J.L., Hanson, K.L., Tapert, S.F., Brown, S.A., Heavy alcohol use, marijuana use, and concomitant use by adolescents are associated with unique and shared cognitive decrements. J. Int. Neuropsychol. Soc. 20 (2014), 784–795.
75. Yurasek, A.M., Aston, E.R., Metrik, J., Co-use of alcohol and cannabis: a review. Curr. Addict. Rep. 4 (2017), 184–193.